Literature DB >> 25315047

Ocular Defect Rehabilitation Using Photography and Digital Imaging: A Clinical Report.

Muaiyed M Buzayan1, Yusnidar T Ariffin2, Norsiah Yunus2, Wan Adida Azina Binti Mahmood2.   

Abstract

Ocular disorders occasionally necessitate surgical intervention that may lead to eye defects. The primary objective in restoring and rehabilitating such defects with an ocular prosthesis is to enable patients to cope better with associated psychological stress and to return to their accustomed lifestyle. A series of detailed steps for custom-made ocular prosthesis fabrication using the advantages of digital photography to replace the conventional oil paint and monopoly iris painting technique are presented in this article. In the present case, a digital photograph of the patient's iris was captured using a digital camera and manipulated on a computer using graphic software to produce a replica of the natural iris. The described technique reduces treatment time, increases simplicity, and permits the patient's natural iris to be replicated without the need for iris painting and special artistic skills.
© 2014 by the American College of Prosthodontists.

Entities:  

Keywords:  Custom-made ocular prosthesis; digital imaging; digital photography; photographic iris

Mesh:

Year:  2014        PMID: 25315047     DOI: 10.1111/jopr.12235

Source DB:  PubMed          Journal:  J Prosthodont        ISSN: 1059-941X            Impact factor:   2.752


  2 in total

1.  Automated Noncontact Facial Topography Mapping, 3-Dimensional Printing, and Silicone Casting of Orbital Prosthesis.

Authors:  Ernesto H Weisson; Mauro Fittipaldi; Carlos A Concepcion; Daniel Pelaez; Landon Grace; David T Tse
Journal:  Am J Ophthalmol       Date:  2020-07-22       Impact factor: 5.258

2.  Three-Dimensional Computer-Aided Design of a Full-Color Ocular Prosthesis with Textured Iris and Sclera Manufactured in One Single Print Job.

Authors:  Annabel L W Groot; Jelmer S Remmers; Dyonne T Hartong
Journal:  3D Print Addit Manuf       Date:  2021-12-09       Impact factor: 5.449

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.